New Atherosclerosis Vaccine Gives Promising Results

July 2011
International Journal of Virology;2011, Vol. 7 Issue 2, p76
Academic Journal
No abstract available.


Related Articles

  • Secondary Prevention of Coronary Heart Disease in Patients with Extracoronary Atherosclerosis: A Need for Accuracy of Low Density Lipoprotein Determination. Senté, Mariano; Pedro-Botet, Juan; Rubiés-Prat, Juan; Vidal-Barraquer, Francesc // Angiology;Mar1996, Vol. 47 Issue 3, p241 

    According to the new guidelines of the National Cholesterol Education Program (NCEP) for secondary prevention in adults with evidence of coronary heart disease or other clinical atherosclerotic disease, lipoprotein analysis is required and classification is based on low density lipoprotein (LDL)...

  • The Dynamics of Oxidized LDL during Atherogenesis. Itabe, Hiroyuki; Obama, Takashi; Kato, Rina // Journal of Lipids;2011, p1 

    Accumulating evidence indicates that oxidized low-density lipoprotein (OxLDL) is a useful marker for cardiovascular disease. The uptake of OxLDL by scavenger receptors leads to the accumulation of cholesterol within the foam cells of atherosclerotic lesions. OxLDL has many stimulatory effects on...

  • Preparation and investigation of 99m technetium-labeled low-density lipoproteins in rabbits with experimentally induced hypercholesterolemia. Bozóky, Z.; Balogh, L.; Máthé, D.; Fülöp, L.; Bertók, L.; Jánoki, Gy. A. // European Biophysics Journal;2004, Vol. 33 Issue 2, p140 

    Low-density lipoproteins (LDL) were radiolabeled in atherosclerosis studies. The aim was to investigate the biodistribution and uptake of [sup 99m]Tc-labeled LDL by atherosclerotic plaques in experimentally induced hyperlipidemia. Rabbits were fed a diet containing 2% cholesterol for 60 days to...

  • Ratio of Dense to Buoyant LDL Subclass is Associated with LDL Density Phenotype (VLDL-5). Ahmed, Haitham M.; Elshazly, Mohamed B.; Martin, Seth S.; Blaha, Michael J.; Kulkarni, Krishnaji R.; Jones, Steven R. // Open Chemical & Biomedical Methods Journal;2013, Vol. 6, p1 

    Background: Dense LDL phenotypes are associated with increased atherogenicity, and are commonly evaluated for the purposes of atherosclerosis research and cardiovascular risk discrimination. Objective: To examine the ability of LDL subclasses, expressed as a ratio of dense-to-buoyant subclass,...

  • Lipoprotein Cholesterol and Atherosclerosis. Kruth, Howard S. // Current Molecular Medicine;Dec2001, Vol. 1 Issue 6, p633 

    Progressive accumulation of cholesterol in the arterial wall causes atherosclerosis, the pathologic process underlying most heart attacks and strokes. Low density lipoprotein (LDL), the major carrier of blood cholesterol, has been implicated in the buildup of cholesterol in atherosclerotic...

  • HDL and Inflammation in Atherosclerosis. Spieker, Lukas E.; Ruschitzka, Frank; Luscher, Thomas F.; Noll, Georg // Current Drug Targets - Immune, Endocrine & Metabolic Disorders;Mar2004, Vol. 4 Issue 1, p51 

    Atherosclerotic vascular disease is among the most frequent causes of death worldwide. Current therapeutic strategies concentrate mainly on lowering of low-density lipoprotein (LDL) cholesterol and an impressive reduction in the risk for cardiovascular morbidity and mortality has been achieved....

  • MicroRNA-155 and macrophages: a fatty liaison. Hartmann, Petra; Schober, Andreas; Weber, Christian // Cardiovascular Research;Jul2014, Vol. 103 Issue 1, p5 

    No abstract available.

  • LDL Cholesterol Modulates Human CD34+ HSPCs through Effects on Proliferation and the IL-17 G-CSF Axis. Cimato, Thomas R.; Palka, Beth A.; Lang, Jennifer K.; Young, Rebeccah F. // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Background:Hypercholesterolemia plays a critical role in atherosclerosis. CD34+ CD45dim Lineage- hematopoietic stem/progenitor cells (HSPCs) give rise to the inflammatory cells linked to atherosclerosis. In mice, high cholesterol levels mobilize HSPCs into the bloodstream, and promote their...

  • Cholesterol Redux. Rifkind, Basil M. // JAMA: Journal of the American Medical Association;12/19/90, Vol. 264 Issue 23, p3060 

    Editorial. Provides information on serum cholesterol reduction. Role of serum cholesterol levels in atherosclerosis; Effects of cholesterol reduction on coronary heart disease; Discussion on oxidative modification of low density lipoprotein cholesterol; Drug therapy for cholesterol reduction.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics